Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Danette Guertin"'
Autor:
Brian F. McBride, Bokyung Min, Jeffrey Kluger, Danette Guertin, Nickole N. Henyan, Craig I. Coleman, Burton B. Silver, C. Michael White
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 11, Iss 2, Pp 163-169 (2006)
Background: Intravenous magnesium reduces the QTc interval of patients receiving ibutilide. Whether oral magnesium can reduce the QTc interval associated with oral sotalol and dofetilide is not known. This study was undertaken to evaluate the impact
Externí odkaz:
https://doaj.org/article/f8773355af32424e8a82e76313bced82
Autor:
Meena Azeem, Sanjeev P. Bhavnani, Danette Guertin, Jeffrey Kluger, Dalia Giedrimiene, Craig I Coleman
Publikováno v:
Pacing and Clinical Electrophysiology. 37:1315-1323
Background Inappropriate shocks (IASs) from implantable cardioverter defibrillators (ICDs) are associated with decreased quality of life, but whether they increase healthcare utilization and treatment costs is unknown. We sought to determine the impa
Autor:
Jeffrey Kluger, Danette Guertin, Craig I Coleman, Anupam Kumar, Christopher A. Clyne, Sanjeev P. Bhavnani, Ravi K. Yarlagadda
Publikováno v:
Europace. 16:47-54
Aims Hyponatremia is commonly observed among patients with left ventricular (LV) dysfunction and is a marker for adverse outcomes. We aimed to determine the prognostic significance of pre-implant hyponatremia on the outcomes of death, acute decompens
Autor:
Danette Guertin, Steven Zweibel, Nitesh Sood, Christopher A. Clyne, Meir Friedman, Eric Crespo, Jeffrey Kluger
Publikováno v:
Pacing and Clinical Electrophysiology. 36:945-951
Background The prevalence, predictors, and survival for the development of pacemaker dependence (PD) in patients implanted with an implantable cardioverter defibrillator (ICD) are unknown. Methods This was a retrospective analysis of 1,550 consecutiv
Autor:
Ravi K. Yarlagadda, Craig I Coleman, Christopher A. Clyne, Danette Guertin, Sanjeev P. Bhavnani, Jeffrey Kluger
Publikováno v:
Annals of Noninvasive Electrocardiology. 18:379-388
Background: Current guidelines consider the implantation of an implantable cardioverter defibrillator (ICD) a class III indication in patients with a life expectancy of
Autor:
Vamsimohan Pavuluri, Danette Guertin, J. Kluger, Christopher A. Clyne, Sanjeev P. Bhavnani, Craig I Coleman, Ravi K. Yarlagadda
Publikováno v:
Pacing and Clinical Electrophysiology. 36:878-884
Background Several meta-analyses of the implantable cardioverter-defibrillator (ICD) clinical trials have demonstrated that while men derived a mortality reduction with prophylactic ICD implantation, women did not. These trials also observed that wom
Autor:
Ravi K. Yarlagadda, Jeffrey Kluger, Craig I Coleman, Danette Guertin, Christopher A. Clyne, Sanjeev P. Bhavnani, Charles White
Publikováno v:
Europace. 10:854-859
Aims In patients without implantable cardioverter defibrillators (ICDs), statins have been shown to reduce the incidence of atrial fibrillation and atrial flutter (AF/AFL). We sought to determine if statin therapy could reduce the occurrence of AF/AF
Autor:
C Michael White, Christopher A. Clyne, Brian F. McBride, James S. Kalus, William L. Baker, Danette Guertin, Jeffery Kluger
Publikováno v:
Heart & Lung. 37:67-71
Background Defibrillation threshold (DFT) is the minimum energy required to successfully terminate ventricular fibrillation. Epinephrine has been shown to increase the DFT in the beta-blocker naive, but using cardioselective beta-blockers leads to a
Autor:
Jeffrey Kluger, James S. Kalus, Michael F. Caron, Brian F. McBride, Danette Guertin, C Michael White
Publikováno v:
Pacing and Clinical Electrophysiology. 28:1147-1156
Objectives: To determine the effect of physiologic catecholamine concentrations on the defibrillation threshold (DFT) in patients with implanted cardioverter defibrillators. Background: DFT is the minimum energy delivered by an implanted cardioverter
Publikováno v:
Circulation. 130
Prospective clinical trials have demonstrated that ICD-delivered therapy reduces mortality in patients at risk for sudden cardiac arrest due to ventricular tachycardia (VT). ICDs through anti-tachycardia pacing (ATP) modalities are able to terminate